Nausea Clinical Trial
Official title:
Can Acustimulation Attenuate Postoperative Nausea and Vomiting in Children Who Have Undergone Tonsillectomy/Adenoidectomy?
Postoperative nausea and vomiting (PONV) remain a significant challenge in the investigators
practice. However, pharmaceutical prophylaxis can imply unpleasant adverse effects. It would
therefore be appropriate to consider the use of non-pharmacological methods in preventing
PONV. Acupuncture and acupressure are reported to be effective preventive treatment for
PONV, and the adverse effects are minimal.
Consequently, the investigators will investigate if acupuncture and acupressure can be
implemented as a supplementary to the ordinary treatment in children undergoing surgery for
tonsillectomy and/or adenoidectomy. The study will also focus on the feasibility for
acupuncture and acupressure in the operation theatre. The study and inclusion/exclusion
decisions are conducted after the "intention-to-treat" principle. 126 patients are included,
divided into two groups:
1. Treatment Group - standard treatment and acupuncture performed after induction of
anaesthesia, acupressure administered before awakening
2. Control Group - standard treatment
The primarily endpoints in this study are nausea, retching and vomiting. The effect of
acupuncture/acupressure will be studied with regard to any association with possible factors
of predisposition to PONV, as well as with other factors registered during the study.
Adverse effects from the acupuncture site and wristband will be registered.
Status | Completed |
Enrollment | 154 |
Est. completion date | November 2008 |
Est. primary completion date | November 2008 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 2 Years to 12 Years |
Eligibility |
Inclusion Criteria: - Children scheduled for tonsillectomy and/or adenoidectomy - Informed consent from the parents/guardians Exclusion Criteria: - ASA grade greater than or equal to III (patients with severe systemic disease) - Rash or local infection over an acupuncture point - Emesis during the previous 24 hours - Use of medication with antiemetic effect and/or other antiemetic therapy within the 24 hours before surgery - Gastric or intestinal diseases |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Country | Name | City | State |
---|---|---|---|
Norway | Lovisenberg Diaconale Hospital | Oslo |
Lead Sponsor | Collaborator |
---|---|
National Research Centre of Complementary and Alternative Medicine, Norway | Lovisenberg Diaconale Hospital |
Norway,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Postoperative nausea and vomiting | 24 hours | No | |
Secondary | The effect of the intervention will be studied with regard to any association with possible factors of predisposition to PONV. Adverse effects will also be registered. | 24 hours | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT01649258 -
Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy
|
Phase 1 | |
Completed |
NCT02939287 -
Aprepitant- and Olanzapine- Containing Anti-emetic Regimens With High Dose Melphalan
|
Phase 3 | |
Not yet recruiting |
NCT06464926 -
Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)
|
N/A | |
Not yet recruiting |
NCT06055192 -
Prevalence and Burden of Nausea and Vomiting in Pregnant Women in Switzerland: Survey Purity 2022
|
||
Recruiting |
NCT04091789 -
Sublingual Tablets With Cannabinoid Combinations for the Treatment of Dysmenorrhea
|
Phase 2 | |
Completed |
NCT02462811 -
A Double-Blind, Randomized, Active- and Placebo-Controlled, Multiple-Dose Multi-Center Phase 3 Study of the Safety and Efficacy of CL-108 in the Treatment of Moderate to Severe Acute Pain and Opioid-Induced Nausea and Vomiting (OINV)
|
Phase 3 | |
Completed |
NCT01007500 -
Effect of Dexamethasone Combined With Ondansetron on Postoperative Nausea and Vomiting in Patients With Patient-controlled Analgesia After Video-assisted Thoracoscopic Surgery
|
Phase 4 | |
Recruiting |
NCT00528554 -
Laser Acupuncture Against Nausea in Children
|
N/A | |
Completed |
NCT00537875 -
Evaluation of the Effect of Zingiber Officinalis on Nausea and Vomiting in Patients Receiving Cisplatin Based Regimens
|
N/A | |
Completed |
NCT00394966 -
A Multicenter, Randomized, Controlled Trial of SCH 619734 for the Treatment of Chemotherapy-Induced Nausea and Vomiting (Study P04351AM2)(COMPLETED)
|
Phase 2 | |
Completed |
NCT00947128 -
To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Non-Fasting Conditions
|
Phase 1 | |
Completed |
NCT00946387 -
To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Fasting Conditions
|
Phase 1 | |
Recruiting |
NCT05433636 -
Mindful Waiting Room
|
N/A | |
Not yet recruiting |
NCT04827108 -
Psychometric Properties of the Chinese Version of PeNAT
|
||
Not yet recruiting |
NCT04853303 -
VR to Improve CINV, Sleep and Pain Among Children With Cancer in HK
|
N/A | |
Terminated |
NCT04247100 -
A Study of Randomized Sham-control Auricular TENS Unit Stimulation in Pediatric Functional Gastrointestinal Disorders
|
N/A | |
Recruiting |
NCT04181346 -
Pregabalin for the Prevention of Chemotherapy Induced Nausea and Vomiting
|
Phase 2 | |
Recruiting |
NCT03679182 -
Efficacy and Safety of Olanzapine for the Treatment of Nausea and Vomiting in Palliative Cancer Care
|
Phase 2 | |
Completed |
NCT02618343 -
EMS Use of Isopropyl Alcohol Aromatherapy Versus Ondansetron
|
N/A | |
Terminated |
NCT01405924 -
Fosaprepitant (MK-0517, EMEND® IV) In Salvage Treatment of Chemotherapy-Induced Vomiting (MK-0517-030)
|
Phase 2 |